About Elisabetta Graff
Form D filings for Ostentus Therapeutics from 2021 to 2024 list Elisabetta Graff as president and director.
Elisabetta Graff first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Elisabetta Graff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Elisabetta Graff works with at each company, as listed on that company's latest Form D.
Ostentus Therapeutics, Inc. · Form D, Mar 8, 2024
WG
William Graff
Director and promoter
SW
Stuart Weinstein
Director and promoter